2m 2m 2m 2m 2m 2m 2m
PMV PHARMA (PMVP)
NASDAQ
$1.86+$0.11 (+6.17%)
Price as of Oct 02, 2026 6:06 PM EDT- $93.6MMarket Cap
- 26.81%1-Year Change
- BiotechnologyIndustry
PMV PHARMA (PMVP)
$1.86+$0.11 (+6.17%)
PMVP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.75 | ||
Change | +$0.08 (+4.79%) | ||
Open | $1.68 | ||
High | $1.91 | ||
Low | $1.63 | ||
Previous Close | $1.67 | ||
Volume | 1,647,431 | ||
30-Day Average Volume | 1,069,123 | ||
1-Week Change | 31.09% | ||
1-Month Change | 35.66% | ||
1-Year Change | 26.81% | ||
3-Year Change | -71.50% | ||
5-Year Change | -94.21% | ||
Fundamentals | |||
Shares Outstanding | 53.5M | ||
Total Assets | $82.1M | ||
Market Cap | $93.6M | ||
Enterprise Value | $81.7M | ||
Period: QTR TTM FY | |||
Revenue | $788,000.00 | ||
Net Income | -$18.1M | ||
Free Cash Flow | -$14.6M | ||
EBIT | -$18.1M | ||
EBITDA | -$18.1M | ||
Net Working Capital | $70.8M | ||
EPS | -$0.34 | ||
Enterprise Value/EBITDA | -5 | ||
Enterprise Value/Revenue | 104 | ||
P/B | 1 | ||
P/E | -5 | ||
PEG | N/A | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue